Uyl-de Groot, C.A.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Stem cell transplantation in Europe: Trends and prospects

S.S. Tan, C.A. Uyl-de Groot, P.C. Huijgens, W.E. Fibbe

Journal:

European Journal of Cancer

Year:

2007

Language:

english

File:

PDF, 292 KB

english, 2007

52

Cost-effectiveness and quality of life of granulocyte-colony stimulating factor (filgrastim) after radical vulvectomy and bilateral inguino-femoral lymphadenectomy: results of a randomized clinical trial

Carin A. Uyl-de Groot, Jolanda Gelderblom-den Hartog, Jos G.M. Derksen, Edith A. Symons, Ivonne Buijt, Jacobus van der Velden, Arnold C.M. van Lindert

Journal:

European Journal of Obstetrics & Gynecology and Reproductive Biology

Year:

2004

Language:

english

File:

PDF, 107 KB

english, 2004

53

Economics and health-related quality of life in antiemetic therapy: recommendations for trial design

C.A Uyl-de Groot, S Wait, I Buijt

Journal:

European Journal of Cancer

Year:

2000

Language:

english

File:

PDF, 134 KB

english, 2000

54

The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up

M van Agthoven, B.M van Ineveld, M.F de Boer, C.R Leemans, P.P Knegt, G.B Snow, C.A Uyl-de Groot

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 174 KB

english, 2001

55

Impact of advanced technology in cancer of the head and neck

P. Levendag, D. Baltas, C. Uyl-de Groot, M. Braaksma, J. van Sörnsen de Koste, H. van der Est, M. Dirkx, F. Lagerwaard, A. van den Berg, P. Nowak

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 334 KB

english, 2001

56

OP6. Costs of care in a randomised trial of early hospital discharge after surgery for breast cancer

J Bonnema, AMEA van Wersch, AN van Geel, JFA Pruyn, PIM Schmitz, CA Uyl-de Groot, T Wiggers

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 339 KB

english, 1997

57

Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer

J Bonnema, A.M.E.A van Wersch, A.N van Geel, J.F.A Pruyn, P.I.M Schmitz, C.A Uyl-de Groot, T Wiggers

Journal:

European Journal of Cancer

Year:

1998

Language:

english

File:

PDF, 91 KB

english, 1998

58

PD.18 Can we prioritize treatment modalities for oropharyngeal cancer based on costs of primary treatment, relapse, and grade III/IV complications?

M. van Agthoven, W.M. Nijdam, P.C. Levendag, I. Noever, C.A. Uyl-de Groot

Journal:

Oral Oncology Supplement

Year:

2005

Language:

english

File:

PDF, 128 KB

english, 2005

59

Cancer in the oropharynx: Cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications

Wideke Nijdam, Peter Levendag, Inge Noever, Carin Uyl-de Groot, Michel van Agthoven

Journal:

Radiotherapy and Oncology

Year:

2005

Language:

english

File:

PDF, 283 KB

english, 2005

60

Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial

M van Agthoven, E Vellenga, W.E Fibbe, T Kingma, C.A Uyl-de Groot

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 159 KB

english, 2001

61

CN2 COST-EFFECTIVENESS OFTEMOZOLOMIDE FORTHE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN THE UK

CA Uyl-de Groot, LM Lamers, M Al, M Bent van den, T Gorlia, R Crott, W Mason, R Stupp

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 56 KB

english, 2005

62

PCN22 COSTS OF COMMON TREATMENT OPTIONS FOR INDOLENT FOLLICULAR NON-HODGKIN'S LYMPHOMA

M Van Agthoven, A Hagenbeek, CA Uyl-de Groot

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 64 KB

english, 2005

63

CN7 TREATMENT VARIATION COMPLICATES REAL-WORLD PHARMACOECONOMICS: DAILY CLINICAL PRACTICE OF BORTEZOMIB IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

M Franken, J Gaultney, P Huijgens, WK Redekop, CA Uyl-de Groot

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 74 KB

english, 2009

64

PCN12 EXPLORING THE ROLE OF OUTCOMES RESEARCH IN DUTCH REIMBURSEMENT POLICY: REAL-WORLD PHARMACOECONOMICS OF OXALIPLATIN IN STAGE III COLON CANCER

CWM van Gils, WK Redekop, CJA Punt, CA Uyl-de Groot

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 79 KB

english, 2009

65

PCN18 OUTCOMES RESEARCH OF BORTEZOMIB INDICATED FOR MULTIPLE MYELOMA IN THE CONTEXT OF THE DUTCH REIMBURSEMENT POLICY FOR EXPENSIVE MEDICINES: THREATS TO THE INTERNAL VALIDITY OF THE INCREMENTAL EFFECTIVENESS ESTIMATE

J Gaultney, M Franken, CWM van Gils, P Huijgens, WK Redekop, CA Uyl-de Groot

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 71 KB

english, 2009

66

PSY4 CHALLENGES IN USING THE LITERATURE TO ESTIMATE THE OUTCOMES OF CURRENT RISK STRATIFICATION METHODS IN ADULT PATIENTS WITH PRIMARY ACUTE MYELOID LEUKEMIA

A Leunis, WK Redekop, CA Uyl-de Groot, B Lowenberg

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 97 KB

english, 2009

67

PCN8: COST-UTILITY ANALYSIS OF SEVERAL SECOND-LINE CHEMOTHERAPY SCHEMES FOR PATIENTS WITH METASTATIC BREAST CANCER

CA Uyl-de Groot, N Li, M van Agthoven, P Willemse

Journal:

Value in Health

Year:

2000

Language:

english

File:

PDF, 59 KB

english, 2000

68

MO3 THE DEVELOPMENT AND VALIDATION OF A DECISION MODEL REPRESENTING THE FULL DISEASE COURSE OF ACUTE MYELOID LEUKEMIA

A Leunis, Beers EH van, B Löwenberg, WK Redekop, Groot CA Uyl-De

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 77 KB

english, 2010

69

CN2 REAL-WORLD COST-EFFECTIVENESS OF OXALIPLATIN IN STAGE III COLON CANCER: A SYNTHESIS OF TRIAL DATA WITH DATA FROM DAILY CLINICAL PRACTICE

C van Gils, S de Groot, W Redekop, C Uyl-de Groot

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010

70

HG1 Applying Frailty Model in Longitudinal Survivals of Chronic Diseases

Y. Li, K. Holtzer-Goor, C. Uyl-de Groot, M. Al

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

71

PMD23 Characterization of Focal Liver Lesions by Contrast-Enhanced Ultrasound in the Netherlands: An Economic Evaluation

R. Zaim, P. Taimr, R. De knegt, W. Redekop, C. Uyl-de Groot

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

72

PSY55 Cost of Autologous and Allogeneic Stem Cell Transplantations for Haematological Disease: A Dutch Multicentre Daily Practice Study

H. Blommestein, S. Verelst, J. Cornelissen, P. Huijgens, N. Blijlevens, C. Uyl-de Groot

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 62 KB

english, 2011

73

PGI15 The Cost and Quality of Life of Hepatitis C in the Netherlands

E.M. van Rooijen, D. Hotho, M. Agthoven, A. Van Der Kolk, B.E. Hansen, R. Knegt, C.A. Uyl-De Groot

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

74

Condition-Specific Preference-Based Measures: Benefit or Burden?

Matthijs M. Versteegh, Annemieke Leunis, Carin A. Uyl-de Groot, Elly A. Stolk

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 754 KB

english, 2012

75

PCN6 The Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

S. de Groot, W. Redekop, S. Oosting, E. Oosterwijk, L. Kiemeney, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

76

PRM11 Real-World Data to Calculate Cost-Effectiveness of Monoclonal Antibodies: Problems and Solutions

E.M. van Rooijen, N. van der Linden, C. van Gils, M. Oppe, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

77

PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registries

S. de Groot, H. Blommestein, M. Franken, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 71 KB

english, 2012

78

PCN68 Pharmacoeconomic Evaluation of Rituximab as Maintenance Treatment for Relapsed Follicular Lymphoma: Results of a Real-World Population Based Study

H. Blommestein, D. Issa, M. Pompen, C. Révil, M. Hoogendoorn, P. Joosten, P. Huijgens, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 61 KB

english, 2012

79

PRM3 Turning the Tables to Address the Real Value of Real-World Observational Studies of Novel Anti-Cancer Agents in Multiple Myeloma

J.G. Gaultney, M.G. Franken, W.K. Redekop, P.C. Huijgens, C.A. Uyl-de Groot, P. Sonneveld

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

80

PCN126 Can a Population-Based Patient Registry Improve the Feasibility of Outcomes Research in Multiple Myeloma?

H. Blommestein, M. Franken, S. Verelst, J.G. Gaultney, P. Huijgens, P. Sonneveld, W.K. Redekop, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 59 KB

english, 2012

81

PCN127 Policy Maker, Please Carefully Consider Your Needs: Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?

M.G. Franken, J.G. Gaultney, H.M. Blommestein, P.C. Huijgens, P. Sonneveld, W.K. Redekop, C.A. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 69 KB

english, 2012

82

UT1 The Calculation of Quality of Life Utilities for Acute Leukemia: A Comparison Between EQ5D-5L and QlQ-C30

A. Leunis, W.K. Redekop, B. Lowenberg, C. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 57 KB

english, 2012

83

PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma: A Systematic Review

R. Zaim, W.K. Redekop, R. De Bree, G.A.M.S. Van Dongen, O.S. Hoekstra, C.A. Uyl-de Groot

Journal:

Value in Health

Year:

2012

Language:

english

File:

PDF, 70 KB

english, 2012

84

CN3 IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR CELL-BCG VACCINE (ONCOVAX®) IN PATIENTS WITH STAGE II COLON CANCER: MEDICAL AND ECONOMIC BENEFITS

CA Uyl-de Groot, MG Hanna, MT Groot, P Verboom, HC Hoover, JB Vermorken

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 56 KB

english, 2002

85

PCN1 COST ANALYSIS OF HLA-IDENTICAL SIBLING AND VOLUNTARY UNRELATED ALLOGENEIC BONE MARROW AND PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN ADULTS WITH ACUTE MYELOCYTIC LEUKAEMIA OR ACUTE LYMPHOBLASTIC LEUKAEMIA

MT Groot, M van Agthoven, LF Verdonck, B Löwenberg, AVMB Schattenberg, M Oudshoorn, A Hagenbeek, JJ Cornelissen, C Uyl-de Groot, R Willemze

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 64 KB

english, 2002

86

PCN18 DERIVING A UTILITY WEIGHTED INDEX FROM CONDITION-SPECIFIC MEASURES: PRACTICAL SOLUTIONS FOR ECONOMIC EVALUTIONS

P Kind, CA Uyl-de groot, I Buigt, S Macran

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 63 KB

english, 2002

87

PHM8 INDIRECT COSTS OF BETA THALASSEMIA MAJOR: RESULTS FROM THE ITACA STUDY

M Krol, S Ravera, C Uyl-de Groot, M Cappellini, L Scalone, LG Mantovani

Journal:

Value in Health

Year:

2006

Language:

english

File:

PDF, 72 KB

english, 2006

88

PCHI4: MEDICAL TREATMENT FOR CHRONIC MYELOID LEUKAEMIA (CML):AVERAGE COST EFFECTIVENESS RATIOS OF FIRST AND SECOND LINE TREATMENT

MT Groot, GJ Ossenkoppele, MHH Kramer, G van den Boom, PC Huijgens, CA Uyl-de Groot

Journal:

Value in Health

Year:

2003

Language:

english

File:

PDF, 62 KB

english, 2003

89

PCN62 USE OF A 5-LEVEL EQ-5D IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

KM Holtzer-Goor, SL Thompson, MR Schaafsma, C Uyl-de Groot

Journal:

Value in Health

Year:

2007

Language:

english

File:

PDF, 90 KB

english, 2007

90

CN3 COST-EFFECTIVENESS OF IMATINIB VERSUS INTERFERON (IFN-a) PLUS LOW-DOSE CYTARABINE (ARA-C) FOR NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) IN THE THE NETHERLANDS

MT Groot, KD Anstrom, SD Reed, CA Uyl-de Groot

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 63 KB

english, 2004

91

PCN51 POTENTIAL ECONOMIC AND HEALTH IMPACT OF GENOMICS AND PROTEOMICSTECHNOLOGY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA

WK Redekop, H Vietor, B Lowenberg, CA Uyl-de Groot

Journal:

Value in Health

Year:

2008

Language:

english

File:

PDF, 69 KB

english, 2008

92

Real-world health care costs of relapsed/refractory multiple myeloma during the era of novel cancer agents

Gaultney, J. G., Franken, M. G., Tan, S. S., Redekop, W. K., Huijgens, P. C., Sonneveld, P., Uyl-de Groot, C. A.

Journal:

Journal of Clinical Pharmacy and Therapeutics

Year:

2013

Language:

english

File:

PDF, 572 KB

english, 2013

93

Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer

Bongers, Mathilda L., CoupÃ©, Veerle M.H., Jansma, Elise P., Smit, Egbert F., Uyl-de Groot, Carin A.

Journal:

PharmacoEconomics

Year:

2012

Language:

english

File:

PDF, 225 KB

english, 2012

94

Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

Gils, Chantal W. M., Groot, Saskia, Redekop, William K., Koopman, Miriam, Punt, Cornelis J. A., Uyl-de Groot, Carin A.

Journal:

PharmacoEconomics

Year:

2013

Language:

english

File:

PDF, 488 KB

english, 2013

95

Pet-Based Radiotherapy Treatment Planning Is Highly Cost-Effective Compared to CT-Based Planning: A Model-Based Evaluation

Bongers, M.L., Coupe, V.M.H., De Ruysscher, D., Lambin, P., Oberije, C., Uyl-de Groot, C.A.

Journal:

Value in Health

Year:

2013

Language:

english

File:

PDF, 61 KB

english, 2013

96

1054 Cost analysis comparing brachytherapy versus surgery for carcinoma of the tonsillar fossa and/or soft palate

Nijdam, W., Levendag, P., Noever, I., Uyl-de Groot, C., van, M.Agthoven

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 161 KB

english, 2003

97

Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (Filgrastim); a Less costly alternative to autologous bone marrow transplantation

Groot, C.A.Uyl-de, Richel, D.J., Rutten, F.F.H.

Journal:

European Journal of Cancer

Year:

1994

Language:

english

File:

PDF, 597 KB

english, 1994

98

THE SERVICES.

Groot, C.A.Uyl-de, Richel, D.J., Rutten, F.F.H.

Journal:

Year:

1895

Language:

english

File:

PDF, 412 KB

english, 1895

99

PCN106 Capecitabine Plus Oxaliplatin (CAPOX) Versus Fluorouracil/Leucovorin plus Oxaliplatin (FOLFOX) in Stage III Colon Cancer: A Cost-Minimization Analysis Based on Real World Costs in the Netherlands

van Gils, C.W.M., de Groot, S., Redekop, W.K., Uyl-De Groot, C.A.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 61 KB

english, 2011

100

PSY33 EARLY STAGE ECONOMIC EVALUATION OF PHARMACOGENOMICBASED DIAGNOSTICS IN CHRONIC MYELOID LEUKEMIA

Gaultney, J, Sanhueza, E, Janssen, JJWM, Redekop, WK, Uyl-De, Groot C

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 76 KB

english, 2010